Improving Outcomes Among Medical/Surgical Inpatients With Alcohol Use Disorders
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03258632 |
Recruitment Status :
Completed
First Posted : August 23, 2017
Results First Posted : April 17, 2024
Last Update Posted : April 17, 2024
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Alcohol Use Disorder | Behavioral: Drinking Options - Motivate, Shared Decisions, Telemonitor (DO-MoST) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 155 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Health Services Research |
Official Title: | Improving Outcomes Among Medical/Surgical Inpatients With Alcohol Use Disorders |
Actual Study Start Date : | September 1, 2018 |
Actual Primary Completion Date : | December 26, 2021 |
Actual Study Completion Date : | May 31, 2022 |
Arm | Intervention/treatment |
---|---|
No Intervention: Usual Care
Under usual care, when a patient screens positive on the AUDIT-C administered at intake, a provider (social worker, nurse) provides Brief Intervention (BI), i.e., tells the patient that problems are associated with alcohol use, and about recommended drinking limits; notes the patient as ready to change drinking or not, and as agreeing to treatment or not. If the patient agrees to treatment, specialty addiction services are notified.
|
|
Experimental: Intervention
Patients will attend one 50-minute individual session with a Decision Coach (a trained clinical provider, e.g., MSW). Patients in DO-MoST will also attend 6 biweekly 15-minute telephone sessions from the same Decision Coach.
|
Behavioral: Drinking Options - Motivate, Shared Decisions, Telemonitor (DO-MoST)
Patients will attend one 50-minute individual session with a Decision Coach (a trained clinical provider, e.g., MSW). Patients in DO-MoST will also attend 6 biweekly 15-minute telephone sessions from the same Decision Coach. |
- Time Line Follow Back [ Time Frame: Alcohol use in the past 30 days, assessed at 12-month follow-up ]The investigators will use the Timeline Follow-Back (TLFB) to assess abstinence from alcohol use during the 30 days preceding assessment. The TLFB is a widely used, standardized, calendar-based retrospective self-report assessment to quantify daily alcohol use. The investigators will examine the primary outcome of abstinence from alcohol use at 12-month follow-up.
- Utilization of Substance Use-related Care [ Time Frame: 12 months ]The investigators used a TLFB approach to assess utilization of substance use-related care (any receipt of outpatient and/or residential treatment for alcohol and/or drug problems, yes or no) between baseline and the 12-month follow-up.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Medical-surgical inpatients with alcohol use disorder at the Ann Arbor or Palo Alto VA. Specifically:
- in a current episode of medical-surgical care,
- meet DSM 5 criteria for an AUD
- no specialty addiction treatment or weekly mutual-help group attendance within 60 days prior to the inpatient episode,
- no restricted access due to infection control requirements (e.g., TB, MRSA, C. diff),
- no significant cognitive impairment,
- ongoing access to a cell or land line telephone,
- at least one contact who will continue to know the patient's contact information, and (8) not having participated in an interview for Aim 1 of this project.
Exclusion Criteria:
See inclusion criteria.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03258632
United States, California | |
VA Palo Alto Health Care System, Palo Alto, CA | |
Palo Alto, California, United States, 94304-1290 | |
United States, Michigan | |
VA Ann Arbor Healthcare System, Ann Arbor, MI | |
Ann Arbor, Michigan, United States, 48105 |
Principal Investigator: | Christine Timko, PhD | VA Palo Alto Health Care System, Palo Alto, CA |
Documents provided by VA Office of Research and Development:
Responsible Party: | VA Office of Research and Development |
ClinicalTrials.gov Identifier: | NCT03258632 |
Other Study ID Numbers: |
IIR 15-298 |
First Posted: | August 23, 2017 Key Record Dates |
Results First Posted: | April 17, 2024 |
Last Update Posted: | April 17, 2024 |
Last Verified: | April 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
Alcohol Use Disorder |
Alcoholism Alcohol Drinking Drinking Behavior Alcohol-Related Disorders |
Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |